Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study
dc.contributor.author | Al Saedi, Ahmed | |
dc.contributor.author | Gunawardene, Piumali | |
dc.contributor.author | Bermeo, Sandra | |
dc.contributor.author | Vogrin, Sara | |
dc.contributor.author | Boersma, Derek | |
dc.contributor.author | Phu, Steven | |
dc.contributor.author | Singh, Lakshman | |
dc.contributor.author | Suriyaarachchi, Pushpa | |
dc.contributor.author | Duque, Gustavo | |
dc.date.accessioned | 2018-03-07T22:37:28Z | |
dc.date.available | 2018-03-07T22:37:28Z | |
dc.date.issued | 2018-02 | |
dc.description.abstract | Lamin A is a protein of the nuclear lamina. Low levels of lamin A expression are associated with osteosarcopenia in mice. In this study, we hypothesized that low lamin A expression is also associated with frailty in humans. We aimed to develop a non-invasive method to quantify lamin A expression in epithelial and circulating osteoprogenitor (COP) cells, and to determine the relationship between lamin A expression and frailty in older individuals. COP cells and buccal swabs were obtained from 66 subjects (median age 74; 60% female; 26 non-frail, 23 pre-frail, and 17 frail) participating at the Nepean Osteoporosis and Frailty (NOF) Study. We quantified physical performance and disability, and stratified frailty in this population. Lamin A expression in epithelial and COP cells was quantified by flow cytometry. Linear regression models estimated the relationship between lamin A expression in buccal and COP cells, and prevalent disability and frailty. Lamin A expression in buccal cells showed no association with either disability or frailty. Low lamin A expression values in COP cells were associated with frailty. Frail individuals showed 60% lower levels of lamin A compared to non-frail (95% CI − 36 to − 74%, p < 0.001) and 62% lower levels compared to pre-frail (95%CI − 40 to − 76%, p < 0.001). In summary, we have identified lamin A expression in COP cells as a strong indicator of frailty. Further work is needed to understand lamin A expression as a risk stratifier, biomarker, or therapeutic target in frail older persons. | eng |
dc.identifier.issn | 05315565 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12442/1808 | |
dc.language.iso | eng | spa |
dc.publisher | Elsevier | eng |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
dc.rights.license | Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional | spa |
dc.source | Experimental Gerontology | eng |
dc.source | Vol. 102 (2018) | eng |
dc.source.uri | https://www.sciencedirect.com/science/article/pii/S0531556517307428?via%3Dihub | |
dc.subject | Lamin A | eng |
dc.subject | Aging | eng |
dc.subject | Frailty | eng |
dc.subject | COP cells | eng |
dc.subject | Circulating osteoprogenitors | eng |
dc.subject | Flow cytometry | eng |
dc.title | Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study | eng |
dc.type | article | spa |
dcterms.references | Ahmed, N., Mandel, R., Fain, M.J., 2007. Frailty: an emerging geriatric syndrome. Am. J. Med. 120, 748–753. | eng |
dcterms.references | Akter, R., Rivas, D., Geneau, G., Drissi, H., Duque, G., 2009. Effect of lamin A/C knockdown on osteoblast differentiation and function. J. Bone Miner. Res. 24, 283–293. | eng |
dcterms.references | Bermeo, S., Vidal, C., Zhou, H., Duque, G., 2015. Lamin A/C acts as an essential factor in mesenchymal stem cell differentiation through the regulation of the dynamics of the Wnt/β-catenin pathway. J. Cell. Biochem. 116, 2344–2353. | eng |
dcterms.references | Calvani, R., Marini, F., Cesari, M., Tosato, M., Picca, A., Anker, S.D., von Haehling, S., Miller, R.R., Bernabei, R., Landi, F., Marzetti, E., SPRINTT Consortium, 2017. Biomarkers for physical frailty and sarcopenia. Aging Clin. Exp. Res. 29, 29–34. | eng |
dcterms.references | Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373–383. | eng |
dcterms.references | Clegg, A., Young, J., Iliffe, S., Rikkert, M.O., Rockwood, K., 2013. Frailty in elderly people. Lancet 381, 752–762. | eng |
dcterms.references | De Martinis, M., Franceschi, C., Monti, D., Ginaldi, L., 2006. Inflammation markers predicting frailty and mortality in the elderly. Exp. Mol. Pathol. 80, 219–227. | eng |
dcterms.references | De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C.L., Munnich, A., Le Merrer, M., Lévy, N., 2003. Lamin A truncation in Hutchinson-Gilford progeria. Science 300, 2055. | eng |
dcterms.references | Duque, G., Rivas, D., 2006. Age-related changes in lamin A/C expression in the osteoarticular system: laminopathies as a potential new aging mechanism. Mech. Ageing Dev. 127, 378–383. | eng |
dcterms.references | Duque, G., Li, W., Yeo, L.S., Vidal, C., Fatkin, D., 2011. Attenuated anabolic response to exercise in lamin A/C haploinsufficient mice. Bone 49, 412–418. | eng |
dcterms.references | Egan, K.P., Kim, J.H., Mohler 3rd, E.R., Pignolo, R.J., 2011. Role for circulating osteogenic precursor cells in aortic valvular disease. Arterioscler. Thromb. Vasc. Biol. 31, 2965–2971. | eng |
dcterms.references | Fillenbaum, G.G., Smyer, M.A., 1981. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J. Gerontol. 36, 428–434. | eng |
dcterms.references | Fougère, B., Boulanger, E., Nourhashémi, F., Guyonnet, S., Cesari, M., 2016. Chronic inflammation: accelerator of biological aging. J. Gerontol. A Biol. Sci. Med. Sci. (Dec 21). | eng |
dcterms.references | Fried, L.P., Ferrucci, L., Darer, J., Williamson, J.D., Anderson, G., 2004. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J. Gerontol. A Biol. Sci. Med. Sci. 59, 255–263. | eng |
dcterms.references | Golpanian, S., DiFede, D.L., Pujol, M.V., Lowery, M.H., Levis-Dusseau, S., Goldstein, B.J., Schulman, I.H., Longsomboon, B., Wolf, A., Khan, A., Heldman, A.W., Goldschmidt- Clermont, P.J., Hare, J.M., 2016. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: a phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty. Oncotarget 7, 11899–11912. | eng |
dcterms.references | Gonzalo, S., Kreienkamp, R., Askjaer, P., 2017. Hutchinson-Gilford progeria syndrome: a premature aging disease caused by LMNA gene mutations. Ageing Res. Rev. 33, 18–29. | eng |
dcterms.references | Gruenbaum, Y., Margalit, A., Goldman, R.D., Shumaker, D.K., Wilson, K.L., 2005. The nuclear lamina comes of age. Nat. Rev. Mol. Cell Biol. 6, 21–31. | eng |
dcterms.references | Gunawardene, P., Bermeo, S., Vidal, C., Al-Saedi, A., Chung, P., Boersma, D., Phu, S., Pokorski, I., Suriyaarachchi, P., Demontiero, O., Duque, G., 2016. Association between circulating osteogenic progenitor cells and disability and frailty in older persons: the Nepean osteoporosis and frailty study. J. Gerontol. A Biol. Sci. Med. Sci. 71, 1124–1130. | eng |
dcterms.references | Gunawardene, P., Al Saedi, A., Singh, L., Bermeo, S., Vogrin, S., Phu, S., Suriyaarachchi, P., Pignolo, R.J., Duque, G., 2017. Age, gender, and percentage of circulating osteoprogenitor (COP) cells: the COP study. Exp. Gerontol. 96, 68–72. | eng |
dcterms.references | Horvath, A.R., Kis, E., Dobos, E., 2010. Guidelines for the use of biomarkers: principles, processes and practical considerations. Scand. J. Clin. Lab. Investig. Suppl. 242, 109–111. | eng |
dcterms.references | Huang, W., Sowa, G., 2011. Biomarker development for musculoskeletal diseases. PM R. 3 (6 Suppl 1), S39–44. | eng |
dcterms.references | Hutchison, C.J., Worman, H.J., 2004. A-type lamins: guardians of the soma. Nat. Cell Biol. 6, 1062–1067. | eng |
dcterms.references | Joseph, C., Kenny, A.M., Taxel, P., Lorenzo, J.A., Duque, G., Kuchel, G.A., 2005. Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol. Asp. Med. 26, 181–201. | eng |
dcterms.references | Korf, B., 2008. Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina. N. Engl. J. Med. 358, 552–555. | eng |
dcterms.references | Li, W., Yeo, L.S., Vidal, C., McCorquodale, T., Herrmann, M., Fatkin, D., Duque, G., 2011. Decreased bone formation and osteopenia in lamin a/c-deficient mice. PLoS One 6, e19313. | eng |
dcterms.references | Mahoney, F., Barthel, D., 1965. Functional evaluation: the Barthel index. Md Med. J. 14, 61–65. | eng |
dcterms.references | Morley, J.E., Haren, M.T., Rolland, Y., Kim, M.J., 2006. Frailty. Med. Clin. North Am. 90, 837–847. | eng |
dcterms.references | Pajerowski, J.D., Dahl, K.N., Zhong, F.L., Sammak, P.J., Discher, D.E., 2007. Physical plasticity of the nucleus in stem cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 104, 15619–15624. | eng |
dcterms.references | de Paula Rodrigues, G.H., das Eiras Tamega, I., Duque, G., Spinola Dias Neto, V., 2002. Severe bone changes in a case of Hutchinson-Gilford syndrome. Ann. Genet. 45, 151–155. | eng |
dcterms.references | Pignolo, R.J., Kassem, M., 2011. Circulating osteogenic cells: implications for injury, repair, and regeneration. J. Bone Miner. Res. 26, 1685–1693. | eng |
dcterms.references | Ritt, M., Rádi, K.H., Schwarz, C., Bollheimer, L.C., Sieber, C.C., Gaßmann, K.G., 2016. A comparison of frailty indexes based on a comprehensive geriatric assessment for the prediction of adverse outcomes. J. Nutr. Health Aging 20, 760–767. | eng |
dcterms.references | Rodríguez-Mañas, L., Féart, C., Mann, G., Viña, J., Chatterji, S., Chodzko-Zajko, W., Gonzalez- Colaço Harmand, M., Bergman, H., Carcaillon, L., Nicholson, C., Scuteri, A., Sinclair, A., Pelaez, M., Van der Cammen, T., Beland, F., Bickenbach, J., Delamarche, P., Ferrucci, L., Fried, L.P., Gutiérrez-Robledo, L.M., Rockwood, K., Rodríguez Artalejo, F., Serviddio, G., Vega, E., FOD-CC group, 2013. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition- consensus conference project. J. Gerontol. A Biol. Sci. Med. Sci. 68, 62–67. | eng |
dcterms.references | Searle, S.D., Mitnitski, A., Gahbauer, E.A., Gill, T.M., Rockwood, K., 2008. A standard procedure for creating a frailty index. BMC Geriatr. 8, 24. | eng |
dcterms.references | Soysal, P., Stubbs, B., Lucato, P., Luchini, C., Solmi, M., Peluso, R., Sergi, G., Isik, A.T., Manzato, E., Maggi, S., Maggio, M., Prina, A.M., Cosco, T.D., YT, Wu, Veronese, N., 2016. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res. Rev. 31, 1–8. | eng |
dcterms.references | Tong, J., Li, W., Vidal, C., Yeo, L.S., Fatkin, D., Duque, G., 2011. Lamin A/C deficiency is associated with fat infiltration of muscle and bone. Mech. Ageing Dev. 132, 552–559. | eng |
dcterms.references | Vidal, C., Bermeo, S., Fatkin, D., Duque, G., 2012. Role of the nuclear envelope in the pathogenesis of age-related bone loss and osteoporosis. Bonekey Rep. 2 (1), 62. | eng |
dcterms.references | de Vries, N.M., Staal, J.B., van Ravensberg, C.D., Hobbelen, J.S., Olde Rikkert, M.G., Nijhuis- van der Sanden, M.W., 2010. Outcome instruments to measure frailty: a systematic review. Ageing Res. Rev. 10, 104–114. | eng |
dcterms.references | Walston, J., Hadley, E.C., Ferrucci, L., Guralnik, J.M., Newman, A.B., Studenski, S.A., Ershler, W.B., Harris, T., Fried, L.P., 2006. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on frailty in older adults. J. Am. Geriatr. Soc. 54, 991–1001. | eng |
dcterms.references | Wilson, D., Jackson, T., Sapey, E., Lord, J.M., 2017. Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res. Rev. 36, 1–10. | eng |
dcterms.references | Xue, Q.L., 2011. The frailty syndrome: definition and natural history. Clin. Geriatr. Med. 27, 1–15. | eng |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: